Skip to main content

The Global Microtomes Market Continues To Grow Owing To the Demand from Various Industrial Laboratories and Clinical Research Centers All Over the World despite Its High Cost

 


The microtomes market refers to the sale and distribution of devices used for cutting very thin slices (sections) of biological tissues, plant specimens, or other materials for microscopic examination. They are commonly used in fields such as histology, pathology, and electron microscopy. The market is driven by factors such as increasing demand for tissue-based diagnostic tests, growth in the field of regenerative medicine, and technological advancements in microtomes. The market is segmented into different types of microtomes, including manual, semi-automated, and fully automated, and by end-users such as research laboratories, hospitals, and diagnostic centers.

Market Dynamics                                               

The main driving factor influencing the growth of the microtomes market is the rapid increase of funding and investment for the development of microtomes by the key players and the demand from diagnostic and clinical research laboratories. For instance, in the financial year 2018, the Indian government spent approximately US$ 15,601 million on research and development sectors. Moreover, the demand for microtomes in the practices of histopathology is expected to boost market growth.

However, the high cost and few disadvantages associated with microtomes are the main restraining factor hindering the market growth. For instance, the cost of Leica Microtome RM2255 is between US$ 6900 to US$ 9800 and is very expensive for developing nations of regions such as Asia Pacific, Africa, and the Middle East.

 

Comments

Popular posts from this blog

Life Sciences BPO Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  The growing cost of drug development is augmenting the growth of the global life sciences BPO market. For instance, according to a study by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, the cost of drug development was US$ 2.6 billion, which included average out-of-pocket costs of US$ 1.4 billion and time costs of US$ 1.2 billion. Also, patent expiration is another key factor propelling the growth of the life sciences BPO market. For instance, the patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021. Furthermore, the rising prevalence of chronic disease around the globe is further anticipated to accelerate the growth of the market. North America is projected to lead the global life sciences BPO market due to increasing R&D in cell therapies by key players in the region. For instance, in February 2020, Caribou Biosciences, Inc., a CRISPR genome editin

Mixed Reality in Healthcare Market 2022 Global Industry Analysis By Size, Share, Trends and Growth Till 2028

  Mixed Reality technologies help in improving the productivity of healthcare professionals. They are able to work more productively as they are allowed to fully enjoy all the benefits of both worlds. The main use of augmented reality or virtual reality in this regard is related to the treatment and rehabilitation of patients in a medical environment. There are many pharmaceutical companies that are using the technologies to manufacture better medicines and better equipment. Mixed Reality in Healthcare Market - Market Dynamics Growing demand for digitalization in healthcare sector is a major factor contributing to significant growth of mixed reality in healthcare market . Moreover, the market is expected to witness positive growth with rising prevalence of neurological & psychological disorders across the world.

Structural Heart Devices Market to develop innovative Mitral Valve Repair Technology

  Structural heart devices Market are medical devices with the ability to pump blood by way of the heart. This device is called the ventricular myocardium, and it is what pumps blood from the heart to the various chambers of the body. The structure that this type of heart device has is very basic - a couple of stacks of cells (or more, depending upon the desired function), and a tubing filled with fluid that can allow for the movement of the cells. This particular construction has allowed these devices to be built so that they can pump blood and create heart attacks and heart failure with much greater efficiency. Lack of skilled personnel and low affordability is expected to restrain growth of the global structural heart devices market during the forecast period. However, the emergence of tissue-engineered heart valves and the advent of percutaneous interventions can offer major business opportunities in the global structural heart devicesmarket . Key players involved in the global